AU Patent

AU2017353921A1 — Effective dosing of a child for the treatment of ADHD with methylphenidate

Assigned to Neos Therapeutics LP · Expires 2019-06-13 · 7y expired

What this patent protects

The present invention generally relates to treating attention-deficit disorders (e.g., ADHD) by providing an effective amount of an ADHD-effective agent to a patient in need thereof (e.g., a child).

USPTO Abstract

The present invention generally relates to treating attention-deficit disorders (e.g., ADHD) by providing an effective amount of an ADHD-effective agent to a patient in need thereof (e.g., a child).

Drugs covered by this patent

Patent Metadata

Patent number
AU2017353921A1
Jurisdiction
AU
Classification
—
Expires
2019-06-13
Drug substance claim
No
Drug product claim
No
Assignee
Neos Therapeutics LP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.